Opdivo (nivolumab) for Belfast Trust comes from Bristol Myers Squibb
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct award
- 7 July 2026 to 30 June 2028
Belfast Health and Social Care Trust is buying Opdivo (nivolumab) from Bristol Myers Squibb. The medicine comes as a 600mg/5ml solution for injection in 5 mL vials, for the trust's ongoing clinical treatment.
The trust awarded the £3.3m contract directly in June 2026, with no tender. The two-year contract runs to June 2028.
Contract ends June 2028
- What
- Medicines supply
- Supplier
- Bristol Myers Squibb
- Value
- £3.3m
- How it was bought
- Direct award
- Dates and next
- Jul 2026 to Jun 2028